Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
Decsa Medika Hertanto, Bayu Satria Wiratama, Henry Sutanto, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3419-3428
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

SARS‐CoV‐2 infection and multi-organ system damage: a review
Ali A. Rabaan, Samira Smajlović, Hüseyin Tombuloğlu, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 71
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Giulio Francesco Romiti, Bernadette Corica, Gregory Y.H. Lip, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2490-2490
Open Access | Times Cited: 80
Interleukin-6 blocking agents for treating COVID-19: a living systematic review
Lina Ghosn, Rouba Assi, Theodoros Evrenoglou, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 37
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Murad Alahdal, Eyad Elkord
Clinical Immunology (2022) Vol. 245, pp. 109177-109177
Open Access | Times Cited: 29
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 948-948
Open Access | Times Cited: 27
Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
Hideo Wada, Katsuya Shiraki, Hideto Shimpo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7975-7975
Open Access | Times Cited: 15
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Yasser Mohamed, Yousra A. El‐Maradny, Ahmed K. Saleh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113499-113499
Open Access | Times Cited: 22
A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome—A Pilot Study
Felix Bende, Cristina Tudoran, Ioan Sporea, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2507-2507
Open Access | Times Cited: 27
Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications
Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2539-2539
Open Access | Times Cited: 24
Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019
Hideo Wada, Yuhuko Ichikawa, Minoru Ezaki, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 985-985
Open Access | Times Cited: 19
The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic
Dimitra S. Mouliou
Diseases (2023) Vol. 11, Iss. 1, pp. 20-20
Open Access | Times Cited: 10
Risk factors for invasive mold infection after COVID-19: case-control study
Esma Eren, Hafıze Sav, Zuhal Ozer-Simsek, et al.
African Health Sciences (2025) Vol. 24, Iss. 4, pp. 77-84
Open Access
Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions
Maria João Vidal Alves, Ruana Carolina Cabral da Silva, Sérgio de Sá Leitão Paiva Júnior, et al.
Advances in Therapy (2025)
Open Access
Low Dose of Ti 3 C 2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection
Açelya Yılmazer, Keshav Narayan Alagarsamy, Cemile Gokce, et al.
Small Methods (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 9
Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection
Akitaka Yamamoto, Hideo Wada, Yuhuko Ichikawa, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3775-3775
Open Access | Times Cited: 20
The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality
Johanna Sándor-Kéri, István Benedek, Stefania Polexa, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3015-3015
Open Access | Times Cited: 18
Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis
David Setyo Budi, Ihsan Fahmi Rofananda, Nando Reza Pratama, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109014-109014
Open Access | Times Cited: 11
Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment
Francesco Caruso, Jens Z. Pedersen, Sandra Incerpi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1849-1849
Open Access | Times Cited: 10
Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies
Christie Joshi, Viren Jadeja, Heping Zhou
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7127-7127
Open Access | Times Cited: 12
The Impact of Age on Mortality in Chronic Haemodialysis Population with COVID-19
Ander Vergara, Mireia Molina-Van den Bosch, Néstor Toapanta, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3022-3022
Open Access | Times Cited: 11
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 24, pp. 2022-2028
Closed Access | Times Cited: 7
Harnessing immunity: Immunomodulatory therapies in COVID-19
Tsvetelina Velikova, Hristo Valkov, A Aleksandrova, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment
Narjes Riahi Kashani, Javid Azadbakht, Hassan Ehteram, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Preparing for the next pandemic: Simulation-based deep reinforcement learning to discover and test multimodal control of systemic inflammation using repurposed immunomodulatory agents
Chase Cockrell, Dale Larie, Gary An
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top